|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
76 054 | 84 152 | 110 773 | 155 513 | 142 372 | 131 402 | - | - |
Enterprise Value (EV)2 |
84 045 | 91 569 | 127 770 | 163 061 | 153 521 | 144 255 | 141 289 | 139 179 |
P/E ratio |
36,8x | 27,5x | 26,8x | 44,2x | 28,4x | 22,3x | 18,7x | 16,0x |
Yield |
0,62% | 0,84% | 0,64% | 0,68% | 1,06% | 1,41% | 1,67% | 2,05% |
Capitalization / Revenue |
1,26x | 1,22x | 1,40x | 2,05x | 1,62x | 1,33x | 1,19x | 1,07x |
EV / Revenue |
1,40x | 1,33x | 1,62x | 2,14x | 1,74x | 1,46x | 1,27x | 1,13x |
EV / EBITDA |
20,3x | 16,1x | 17,3x | 26,8x | 19,7x | 16,9x | 14,2x | 12,2x |
Price to Book |
3,34x | 3,32x | 3,78x | 4,70x | 3,88x | 3,17x | 2,80x | 2,47x |
Nbr of stocks (in thousands) |
3 927 361 | 3 927 708 | 3 935 015 | 3 948 109 | 3 953 179 | 3 954 422 | - | - |
Reference price (CNY) |
19,4 | 21,4 | 28,2 | 39,4 | 36,0 | 33,2 | 33,2 | 33,2 |
Announcement Date |
03/27/2018 | 03/27/2019 | 03/25/2020 | 03/24/2021 | 03/30/2022 | - | - | - |
1 HKD in Million 2 CNY in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
60 156 | 68 977 | 79 030 | 76 035 | 88 141 | 98 862 | 110 886 | 123 252 |
EBITDA1 |
4 145 | 5 674 | 7 405 | 6 092 | 7 774 | 8 550 | 9 970 | 11 445 |
Operating profit (EBIT)1 |
2 972 | 3 835 | 4 649 | 3 955 | 5 378 | 5 923 | 7 104 | 8 347 |
Operating Margin |
4,94% | 5,56% | 5,88% | 5,20% | 6,10% | 5,99% | 6,41% | 6,77% |
Pre-Tax Profit (EBT)1 |
2 625 | 3 853 | 5 605 | 4 155 | 5 868 | 7 079 | 8 463 | 9 956 |
Net income1 |
2 048 | 3 043 | 4 105 | 3 525 | 5 026 | 5 874 | 7 023 | 8 261 |
Net margin |
3,40% | 4,41% | 5,19% | 4,64% | 5,70% | 5,94% | 6,33% | 6,70% |
EPS2 |
0,53 | 0,78 | 1,05 | 0,89 | 1,27 | 1,49 | 1,77 | 2,08 |
Dividend per Share2 |
0,12 | 0,18 | 0,18 | 0,27 | 0,38 | 0,47 | 0,56 | 0,68 |
Announcement Date |
03/27/2018 | 03/27/2019 | 03/25/2020 | 03/24/2021 | 03/30/2022 | - | - | - |
1 CNY in Million 2 CNY |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: December
|
2017 S2 |
2018 S1 |
2018 S2 |
2019 S1 |
2019 S2 |
2020 S1 |
2020 S2 |
2021 S1 |
2021 S2 |
2022 S1 |
2022 S2 |
Net sales1 |
30 690 | 34 474 | 34 503 | 39 857 | 39 173 | 37 533 | 38 501 | 45 905 | 42 236 | 48 612 | 49 460 |
EBITDA |
- | - | - | - | - | - | - | - | - | - | - |
Operating profit (EBIT)1 |
1 167 | 1 946 | 1 889 | - | - | 1 714 | 2 242 | 3 030 | 2 348 | 3 116 | 2 904 |
Operating Margin |
3,80% | 5,64% | 5,48% | - | - | 4,57% | 5,82% | 6,60% | 5,56% | 6,41% | 5,87% |
Pre-Tax Profit (EBT) |
1 136 | - | 1 836 | - | - | - | 2 752 | - | 2 471 | - | - |
Net income |
920 | 1 562 | 1 481 | - | - | 1 212 | 2 314 | 2 947 | 2 079 | - | - |
Net margin |
3,00% | 4,53% | 4,29% | - | - | 3,23% | 6,01% | 6,42% | 4,92% | - | - |
EPS |
- | - | - | - | - | 0,31 | - | - | - | - | - |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - |
Announcement Date |
03/27/2018 | 08/29/2018 | 03/27/2019 | 08/28/2019 | 03/25/2020 | 08/26/2020 | 03/24/2021 | 08/25/2021 | 03/30/2022 | - | - |
1 CNY in Million |
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
7 991 | 7 417 | 16 997 | 7 547 | 11 149 | 12 853 | 9 886 | 7 777 |
Net Cash position1 |
- | - | - | - | - | - | - | - |
Leverage (Debt / EBITDA) |
1,93x | 1,31x | 2,30x | 1,24x | 1,43x | 1,50x | 0,99x | 0,68x |
Free Cash Flow1 |
-1 146 | 2 953 | -5 225 | -769 | -4 590 | 3 885 | 5 234 | 6 675 |
ROE (Net Profit / Equities) |
9,43% | 12,7% | 15,1% | 11,4% | 14,4% | 14,7% | 15,7% | 16,3% |
Shareholders' equity1 |
21 725 | 23 908 | 27 170 | 31 057 | 34 904 | 40 048 | 44 796 | 50 636 |
ROA (Net Profit / Asset) |
3,82% | 4,88% | 5,66% | 4,44% | 5,64% | 5,76% | 6,55% | 7,04% |
Assets1 |
53 632 | 62 298 | 72 534 | 79 342 | 89 121 | 102 050 | 107 211 | 117 362 |
Book Value Per Share2 |
5,80 | 6,46 | 7,44 | 8,38 | 9,28 | 10,5 | 11,9 | 13,4 |
Cash Flow per Share2 |
1,41 | 1,63 | 1,61 | 1,35 | 1,91 | 1,96 | 2,25 | 3,01 |
Capex1 |
2 283 | 3 410 | 11 532 | 6 116 | 12 135 | 5 467 | 5 375 | 5 287 |
Capex / Sales |
3,80% | 4,94% | 14,6% | 8,04% | 13,8% | 5,53% | 4,85% | 4,29% |
Announcement Date |
03/27/2018 | 03/27/2019 | 03/25/2020 | 03/24/2021 | 03/30/2022 | - | - | - |
1 CNY in Million 2 CNY |
|
| |
|
|
Reckitt to sell China baby formula business for $2.2 billion |
Capitalization (HKD) |
153 629 281 102 |
Capitalization (USD) |
19 578 091 131 |
Net sales (CNY) |
88 141 475 000 |
Net sales (USD) |
13 132 511 137 |
Number of employees |
44 629 |
Sales / Employee (CNY) |
1 974 982 |
Sales / Employee (USD) |
294 260 |
Free-Float |
76,8% |
Free-Float capitalization (HKD) |
118 006 389 547 |
Free-Float capitalization (USD) |
15 038 408 251 |
Avg. Exchange 20 sessions (CNY) |
457 604 051 |
Avg. Exchange 20 sessions (USD) |
68 180 051 |
Average Daily Capital Traded |
0,30% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|